Skip to main content
News
World
Business
Entertainment
Sports
Tech and Science
Health
Toggle dark mode
Open menu
Menu
News
World
Business
Entertainment
Sports
Tech and Science
Health
Tag:
U.S. Food and Drug Administration; United States Food and Drug Administration; FDA; Food and Drug Administration (FDA); Food and Drug Administration
May 11, 2026
FDA Approves Ocrelizumab for Children With Relapsing-Remitting Multiple Sclerosis
May 2, 2026
FDA Authorizes Expanded Access for RAS(ON) Inhibitor After Survival Doubles